Skip to content

Psilocybin: all studies

Page 273 of 440: studies 2,721 to 2,730 of 4,399, newest first. Back to the psilocybin overview

Research

Psychoactive substances as a last resort—a qualitative study of self-treatment of migraine and cluster headaches

Harm Reduction Journal September 4, 2017 Martin Andersson, Mari Persson, Anette Kjellgren 93 citations

BACKGROUND: Treatment resistant cluster headache and migraine patients are exploring alternative treatments online. The aim of this study was to improve comprehension regarding the use of non-established or alternative pharmacological treatments used by sufferers of cluster headaches and migraines. METHODS: A qualitative thematic analysis of the users' own accounts presented in online forum...

MDA, MDMA, and other “mescaline‐like” substances in the US military's search for a truth drug (1940s to 1960s)

Drug Testing and Analysis August 29, 2017 Torsten Passie, Udo Benzenhöfer 43 citations

Abstract This article describes the context in which 3,4‐methylenedioxyamphetamine (MDA), 3,4‐methylenedioxymethamphetamine (MDMA) and other mescaline‐like compounds were explored as hallucinogens for military and intelligence purposes from the 1940s to the 1960s. Germans first tested mescaline as a “truth drug” in a military context. In the 1940s, the United States military started testing...

A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment

Journal of Psychedelic Studies August 29, 2017 Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, João Felipe Morel Alexandre et al. 39 citations

Objective This report documents the phenomenology of the subjective experiences of 22 patients with substance-related disorders who were involved in a treatment combining cognitive–behavioral therapy and hospital sessions with ibogaine in Brazil. Methods Participants underwent a one-to-one semi-structured interview exploring the subjective effects of ibogaine. We employed interpretative...

Psychedelic Drugs as Therapeutics: No Illusions About the Challenges

Clinical Pharmacology & Therapeutics August 24, 2017 Edward M. Sellers, Deborah B. Leiderman 27 citations

Interest in the potential therapeutic benefits of psychedelic agents has recently increased. In addition to psilocybin, a wide variety of agents with psychedelic properties have been proposed and partially tested. However, the challenges of obtaining approval to market a restricted psychotomimetic agent are formidable.

DOI: 10.1002/cpt.776 (opens in new tab) Psilocybin Psychotomimetic Hallucinogen Illusion +3

The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant

Psychopharmacology August 23, 2017 Ben Sessa 92 citations

Given the plethora of new studies and published papers in the scientific press and the increasingly emerging presence of articles about positive psychedelic experiences appearing in the popular media, there is little doubt that we are in the midst of a Psychedelic Renaissance. The classical psychedelic drugs LSD and psilocybin and the entactogen MDMA are showing promise as tools to assist...

Jeremy Shaw's DMT

Performance Research August 18, 2017 Jennifer Fisher 1 citation

This article examines DMT by Jeremy Shaw, a Berlin-based Canadian artist whose oeuvre has investigated altered states. For this 2004 video work, Shaw administered the hallucinogen dimethyltryptamine to a group of friends and videotaped their experiences. I am interested in how Shaw curates the psychedelic session as a performance of the drug’s agency and aesthetic power. A powerful entheogen...

NATURALIZING PSYCHEDELIC SPIRITUALITY

Zygon: Journal of Religion and Science August 18, 2017 Chris Letheby 18 citations

A pressing philosophical problem is how to respond to the existential, anxiety and disenchantment resulting from a naturalistic worldview that eschews transcendent foundations for meaning and value. This problem is becoming more urgent as the popularization of neuroscientific findings renders a disenchanted conception of human beings ever more vivid, compelling, and widespread. I argue that the...

DOI: 10.1111/zygo.12353 (opens in new tab) Psilocybin Spirituality Disenchantment Transformative learning +7

LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark

Nordic Journal of Psychiatry July 5, 2017 Jens Knud Larsen 15 citations

Despite the significant limitations to a retrospective design, this database warrants caution in mental health patients. The use of LSD and psilocybin in mental health patients may be associated with serious short- and long-term side effects. Until further trials with rigorous designs have cleared these drugs of their potential harms, their clinical utility in these groups of patients has not...

DOI: 10.1080/08039488.2017.1336251 (opens in new tab) Psilocybin Danish Hallucinogen Retrospective cohort study +2

Psychotherapie mit adjuvanter Gabe von serotonergen psychoaktiven Substanzen – Möglichkeiten und Hindernisse

Fortschritte der Neurologie · Psychiatrie July 1, 2017 Tomislav Majić, Henrik Jungaberle, Timo Torsten Schmidt et al. 10 citations

Zusammenfassung Hintergrund Der Einsatz von serotonergen Halluzinogenen (Psychedelika) wie Lysergsäure-Diethylamid (LSD) und Psilocybin und Entaktogenen wie 3,4-Methylendioxymethamphetamin (MDMA) im Rahmen von Psychotherapie ist in den letzten Jahren wieder zunehmend ins Licht des wissenschaftlichen Interesses gerückt. Die vorliegende Arbeit fasst die aktuelle Evidenz zur substanzunterstützten...

Developing Guidelines and Competencies for the Training of Psychedelic Therapists

Journal of Humanistic Psychology June 29, 2017 Janis Phelps 215 citations

Research since the 1950s has shown that psychedelic-assisted psychotherapy has had significant positive effects in reductions of specific clinical symptoms and increases in quality of life as measured on a variety of indices. The intensity of focus on evidence-based outcomes, however, has resulted in a paucity of active discussions and research on the core competencies of the therapists...

DOI: 10.1177/0022167817711304 (opens in new tab) Psilocybin Context archaeology Psychotherapist Neglect +2